Investors / China / Qiming Venture Partners
Qiming Venture Partners
Venture capital · Shanghai, China · Asia Pacific
Qiming Venture Partners is a China-based venture capital firm founded in 2006 that manages USD and RMB funds and invests in early- and growth-stage companies. It focuses on technology and healthcare innovation, and has invested in over 580 companies.
Invests inHealthcare & Biotech
In its own wordstechnologyhealthcareartificial intelligenceroboticssemiconductorsdigital health
Your fit with Qiming Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsQiming Venture Partners lists 159 checked portfolio companies on its own site and is named in 29 funding rounds, 6 of them as lead. Its most frequent entry is Series A, 29% of the companies with a known first round. Its largest themes are Healthcare & Biotech (36%), AI & Machine Learning (15%) and Enterprise Software (10%). 79% of its companies are based in China. It invests most often alongside Lilly Asia Ventures, 5Y Capital and HSG.
Counts come from funding rounds that name Qiming Venture Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Qiming Venture Partners' whole history. Rounds on record name 27 companies; its own site lists 159. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 17% |
| Series A | 29% |
| Series B | 29% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 7 | 3 |
| '26 | 22 | 3 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 98th | 162 companies |
| Recent activity | 99th | 24 rounds in 12 months |
| Early stage | 57th | 17% of entries at pre-seed or seed |
| Evidence | 61th | 4% of companies confirmed by a round |
| Sector focus | 65th | 36% in its largest sector |
| Reach | 95th | 10 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 36% | 15% |
| AI & Machine Learning | 15% | 18% |
| Enterprise Software | 10% | 8% |
| Industrial & Manufacturing | 6% | 7% |
| Fintech | 5% | 12% |
| E-commerce & Marketplaces | 5% | 6% |
| Consumer | 4% | 3% |
| Media & Entertainment | 4% | 4% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Lilly Asia Ventures | 8 |
| 5Y Capital | 6 |
| HSG | 6 |
| IDG Capital | 4 |
| RA Capital | 4 |
| TF Capital | 4 |
| BioTrack Capital | 3 |
| Decheng Capital | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers15698%
- No longer answers00%
- Points to another company32%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Lilly Asia Ventures
Compare Qiming Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Qiming Venture Partners| Date | Company | Stage |
|---|---|---|
| 10 Sept 2026 | Series B | |
| 28 Aug 2026 | Series C+ | |
| 27 Aug 2026 | Series C+ | |
| 4 May 2026 | Series B | |
| 29 Apr 2026 | Series A | |
| 27 Apr 2026 | Series A | |
| 10 Apr 2026 | Series C+ Led | |
| 8 Apr 2026 | Series C+ |
Round details for Qiming Venture Partners
Amounts, full round histories and every co-investor in Qiming Venture Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
159 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company provides online mini games. | Enterprise SoftwareGaming | Portfolio page | ||
| Abogen Biosciences develops medicines through RNA innovations | Healthcare & Biotech | Portfolio page | ||
| The company provides software management and diagnostic solutions for the automotive and internet of things industries. | Industrial & ManufacturingConsumer | Portfolio page | ||
| AirQuality manufactures air purification products, including air disinfection machines, air filters, oil fume purifiers, and sterilization and deodorization machines. | Industrial & ManufacturingHealthcare & Biotech | Portfolio page | ||
| Akulaku provides financial services, including installment payments and cash loans, to its users. | Fintech | Portfolio page | ||
| Alamar Biosciences develops and provides proteomics products and services, including assays and analysis solutions for various fields such as immunology, neurology, and oncology. | Healthcare & Biotech | Portfolio page | ||
| Amoy Diagnostics develops and provides diagnostic products and services for precision medicine, particularly in the field of cancer diagnosis. | Healthcare & Biotech | Portfolio page | ||
| Antengene is a company that discovers, develops, manufactures, and commercializes therapies, with a focus on hematologic malignancies and solid tumors. | Healthcare & Biotech | Portfolio page | ||
| Aohua Endoscopy produces endoscopy systems and related devices. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company develops targeted therapies that harness the immune system and target specific molecular pathways to combat cancer. | Healthcare & Biotech | Portfolio page | ||
| Asieris Pharmaceuticals focuses on the fields of urological tumors and women's health, including breast cancer and gynecological tumors. | Healthcare & Biotech | Portfolio page | ||
| Atom Semiconductor develops high-performance analog chips for consumer and industrial IoT systems. | Industrial & ManufacturingConsumer | Portfolio page | ||
| Aureka Biotechnologies develops life-saving medicines using artificial intelligence and data-driven design | Healthcare & Biotech | Apr 2026Series A | Funding round | |
| AusperBio uses cookies and other technologies to improve its website. | Healthcare & Biotech | Sept 2025Series B · 2 rounds | Page + round | |
| The company develops and provides AI solutions and semiconductor products for various applications, including terminal computing, smart cars, and edge computing. | AI & Machine LearningSpace & Defense | Portfolio page | ||
| The company develops and operates mobile and web games. | GamingEnterprise Software | Portfolio page | ||
Healthcare & BiotechFintech | Portfolio page | |||
| Beva provides audio content for children, including songs, stories, and educational materials. | Enterprise SoftwareMedia & Entertainment | Portfolio page | ||
| Portfolio page |
About this data
site last read 13 Nov 2026- Site
- qimingvc.com
- Last read
- 13 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 7 Sept 2025
- Companies checked
- 159
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Qiming Venture Partners' profile as data
Pull Qiming Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/qimingvc.com
# also
GET /v1/firms/qimingvc.com/portfolio
GET /v1/firms/qimingvc.com/coinvestors
GET /v1/firms/qimingvc.com/news